AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $17.16 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.

Earnings